Spatial and temporal resolution of metabolic dysregulation in the Sugen hypoxia model of pulmonary hypertension
Open Access
- 2 July 2023
- journal article
- research article
- Published by Wiley in Pulmonary Circulation
- Vol. 13 (3) , e12260
Abstract
Although PAH is partially attributed to disordered metabolism, previous human studies have mostly examined circulating metabolites at a single time point, potentially overlooking crucial disease biology. Current knowledge gaps include an understanding of temporal changes that occur within and across relevant tissues, and whether observed metabolic changes might contribute to disease pathobiology. We utilized targeted tissue metabolomics in the Sugen hypoxia (SuHx) rodent model to investigate tissue‐specific metabolic relationships with pulmonary hypertensive features over time using regression modeling and time‐series analysis. Our hypotheses were that some metabolic changes would precede phenotypic changes, and that examining metabolic interactions across heart, lung, and liver tissues would yield insight into interconnected metabolic mechanisms. To support the relevance of our findings, we sought to establish links between SuHx tissue metabolomics and human PAH ‐omics data using bioinformatic predictions. Metabolic differences between and within tissue types were evident by Day 7 postinduction, demonstrating distinct tissue‐specific metabolism in experimental pulmonary hypertension. Various metabolites demonstrated significant tissue‐specific associations with hemodynamics and RV remodeling. Individual metabolite profiles were dynamic, and some metabolic shifts temporally preceded the emergence of overt pulmonary hypertension and RV remodeling. Metabolic interactions were observed such that abundance of several liver metabolites modulated lung and RV metabolite‐phenotype relationships. Taken all together, regression analyses, pathway analyses and time‐series analyses implicated aspartate and glutamate signaling and transport, glycine homeostasis, lung nucleotide abundance, and oxidative stress as relevant to early PAH pathobiology. These findings offer valuable insights into potential targets for early intervention in PAH.Keywords
Funding Information
- Pulmonary Hypertension Association (Aldrighetti Young Investigator Award)
- National Heart, Lung, and Blood Institute (K08HL132055, K23HL153781, R01HL132153)
This publication has 42 references indexed in Scilit:
- The Emerging Role of Metabolomics in the Development of Biomarkers for Pulmonary Hypertension and other Cardiovascular Diseases (2013 Grover Conference Series)Pulmonary Circulation, 2014
- The Metabolic Theory of Pulmonary Arterial HypertensionCirculation Research, 2014
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012
- Metabolomic Analysis of Bone Morphogenetic Protein Receptor Type 2 Mutations in Human Pulmonary Endothelium Reveals Widespread Metabolic ReprogrammingPulmonary Circulation, 2012
- Joint Identification of Multiple Genetic Variants via Elastic‐Net Variable Selection in a Genome‐Wide Association AnalysisAnnals of Human Genetics, 2010
- Formation of Plexiform Lesions in Experimental Severe Pulmonary Arterial HypertensionCirculation, 2010
- MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic dataNucleic Acids Research, 2010
- Measurement of cardiac function using pressure–volume conductance catheter technique in mice and ratsNature Protocols, 2008
- Large-Scale Human Metabolomics Studies: A Strategy for Data (Pre-) Processing and ValidationAnalytical Chemistry, 2005
- Localization and function of the brain excitatory amino acid transporter type 1Bin cardiac mitochondriaJournal of Molecular and Cellular Cardiology, 2004